S&P Futures
3,913.50 +9.75 (+0.25%) Dow Futures
31,516.00 +95.00 (+0.30%) Nasdaq Futures
12,065.50 +25.00 (+0.21%) Russell 2000 Futures
1,777.50 +7.70 (+0.44%) Crude Oil
110.80 +1.23 (+1.12%) Gold
1,828.20 +3.40 (+0.19%)
Nkarta, Inc. (NKTX)
After hours:
- Simply Wall St.
What Is The Ownership Structure Like For Nkarta, Inc. (NASDAQ:NKTX)?
A look at the shareholders of Nkarta, Inc. ( NASDAQ:NKTX ) can tell us which group is most powerful. Large companies...
- Zacks
Wall Street Analysts Predict a 209% Upside in Nkarta, Inc. (NKTX): Here's What You Should Know
The consensus price target hints at a 209.4% upside potential for Nkarta, Inc. (NKTX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
- GlobeNewswire
Nkarta to Participate at Upcoming Investor Conference
SOUTH SAN FRANCISCO, Calif., May 31, 2022 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat cancer, today announced its participation at an upcoming investor conference: Cowen 3rd Annual Oncology Innovation SummitJune 2, 202211:00 a.m. ET – fireside chat A simultaneous webcast of the event will be available on the Investors section of Nkarta’s website, www.nkartatx.com, and a replay will be archived on t
